SEC Form EFFECT filed by Eagle Pharmaceuticals Inc.
$EGRX
Biotechnology: Pharmaceutical Preparations
Health Care
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 9, 2024 |
| Accession Number: | 0001104659-24-123690 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||